Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment

CompletedOBSERVATIONAL
Enrollment

1,102

Participants

Timeline

Start Date

November 20, 2017

Primary Completion Date

March 18, 2020

Study Completion Date

July 13, 2020

Conditions
Osteoarthritis
Interventions
DRUG

Theraflex, BAY 874017

The first three weeks which do have a different posology (3 capsules a day) according to the label should be entered as a distinct period to the treatment period with a recommended posology of 2 capsules a day

Trial Locations (2)

115522

Sci-Res Institute of Rheumatology n.a. V.A. Nasonova of RAMS, Moscow

Unknown

Many locations, Multiple Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT03330288 - Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment | Biotech Hunter | Biotech Hunter